Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adding Ankle Brachial Index to Traditional Framingham Risks Can Improve All-cause Mortality and Cardiac Mortality Prediction in Medium and High Framingham Risk Score Patients: A China Prediction Model

NCT04811547 is registered in ClinicalTrials.gov with Shanghai 10th People's Hospital as lead sponsor.

NCT NCT04811547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04811547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adding Ankle Brachial Index to Traditional Framingham Risks Can Improve All-cause Mortality and Cardiac Mortality Prediction in Medium and High Framingham Risk Score Patients: A China Prediction Model
Lead sponsor
Shanghai 10th People's Hospital
Phase
Observational
Overall status
Completed
Start date
November 20, 2011
Completion date
May 10, 2017
Enrollment
3,687 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ankle brachial index